Brief: Galera Therapeutics Q2 EPS USD -0.48
14/08/2023 14:22
Aug 14 (Reuters) - Galera Therapeutics Q2 net income USD -20.712 million. * Q2 income from operations USD -16.807 million * Q2 cash & investments USD 38.8 million * Q2 EPS USD -0.48
Recent news on Obsidian Therapeutics
See all newsBrief: Obsidian Therapeutics - Files Prospectus Relates To Resale Of Up To 29,164,045 Shares Of Common Stock By Selling Stockholders- SEC Filing
NASDAQ RESUMED AT 09:40 AM
NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 09:31 AM
NASDAQ RESUMED AT 11:05 AM
NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 11:00 AM